NextGen Peptides

MK-2866, also known as ostarine or Enobosarm, is an investigational selective androgen receptor modulator. for the treatment of conditions such as muscle wasting and osteoporosis. Ostarine  can improve strength and promote muscle growth. 

Sarms like Ostarine are taken to inhibit muscle loss when cutting calories in the diet. Users can take one dose daily for 6 to 8 weeks to aid recomposition. Ostarine has a half-life of 24 hours (according to most medically reviewed research and studies), so taking it multiple times per day is not necessary. One dose of 10-20mg every day is all that is required. 

GW501516 (also known as GW-501,516, GW1516, GSK-516, Cardarine, and as Endurobol) is a PPARδ receptor agonist that was invented in a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s. 

It entered clinical development as a drug candidate for metabolic and cardiovascular diseases. Cardarine can help to improve stamina, endurance, and boost fat loss. 

For increased endurance, Cardarine can be used to extend the oxygen intake of muscle fibres, therefore making it a great Sarm to include in your stack if you are looking to develop stamina without the extended recovery. Cardarine is often used for 6 to 8 weeks alongside a stamina

UK Shipping Information 

All orders are processed on the day they are received and posted out the next working day. All orders to the UK are shipped via Royal Mail Secure Recorded Delivery. Orders placed during workdays will be received on the next working day. Orders placed before 3pm on Friday will be received on Monday. Orders placed after 3pm on Friday will be dispatched on Monday. Bank holidays are not considered working day.  

When will you despatch my order? 

We

Oxytocin is a nonapeptide hormone primarily synthesized in magnocellular neurons of the paraventricular and supraoptic nuclei of the hypothalamus. It is known best for its role in stimulating uterine contraction and lactation and is important for social memory and attachment, sexual and maternal behavior, and aggression. Additionally, it has been implicated in various non-social behaviors, including learning, anxiety, feeding, and pain perception.

Oxytocin side effects

Oxytocin may have some side effects, including redness or itching at the site of injection, headache, nausea, vomiting, abdominal cramping, and pain. These potential side effects should be accounted for during a trial. However, there are no known health risks associated with Oxytocin injections, especially when compared to traditional hormone-based metabolic, strengthening, and growth treatments, as studied side by side in animal studies.

Oxytocin dosage

The

MGF stands for mechano growth factor, previously termed IGF-IEb mRNA. It’s a peptide naturally secreted in response to muscle injury and resistance training. It’s an analog of human insulin-like growth factor 1 (IGF-1), so it acts on the same receptors and has similar muscle growth stimulating effects. MGF can encourage the repair and growth of wasted tissues.

MGF side effects

MGF has few if any side effects such as redness or itching at site of injection and low blood sugar which should be accounted for during trial. There are no known health risks associated with MGF injections, especially when compared to traditional hormone-based metabolic, strengthening and growth treatments when compared side by side in animal studies.

MGF dosage

The recommended dosage for MGF is 200-300 mcg two to three times weekly, intramuscularly per injection at animal trial. Injection should be given on an empty stomach,

Also known as Ipam, Ipamorelin Acetate, IPAM, NNC-26-0161 Ipamorelin is similar to growth hormone releasing peptide, notably GHRP-6 and GHRP-2. It shares similar characteristics with GHRP2 although it doesn’t induce hunger, and it lacks ghrelin’s lipogenic properties. It can act in synergy with Growth Hormone Releasing Hormone, or with Sermorelin and Modified GRF 1-29. Ipam also shares close similarities with GHRP-6 although it lacks the side effects that accompany GHRP-6.

IPAMORELIN side effects

IPAMORELIN has few if any side effects such as redness or itching at site of injection and some increase flushing, headaches and flushing which should be accounted for during trial. There are no known health risks associated with IPAMORELIN injections, especially when compared to traditional hormone-based metabolic, strengthening and growth treatments when compared side by side in animal studies.

IPAMORELIN dosage

Also known as IGF1A, IGF-1, IGF1, Somatomedin C, Insulin-like growth factor 1, IGF-1 Des(1-3), Des1-3, Des 1-3, Des (1-3), IGF-1 (4-70), IGF DES IGF 1 DES is a polypeptide amino chain that is made up of 67 different amino acids. Studies have shown that this research peptide has high anabolic properties. IGF-1 DES’s tests on animals determined that its functionality is related to hypergenesis, or hyperplasia, noted by an increase in cellular proliferation. IGF DES’s works at the time and location it needs to, for example, needing skin regeneration, cell repair or wound healing. Most impressively, studies also showed a direct correlation between the presence of this peptide and neuroregeneration. This opens a huge window of opportunity for further research into IGF1-DES's ability to increase lean body mass, induce fat loss and increase physical endurance.

IGF1-DES side effects

IGF1-DES has few if any side effects such as redness or itching at site

Also known as Insulin Growth Factor 1 Long R3 IGF-1 LR3 is a single chain of polypeptides which consists of 83 amino acids. The growth factor IGF1 has many other effects which helps promoting growth and development in growth hormone (GH; MIM 139250). There is a long-term analog of IGF-1 human growth factor i-e LR3, which is responsible for support of recombinant biopharmaceuticals manufacture at large.

IGF1-LR3 side effects

IGF1-LR3 has few if any side effects such as redness or itching at site of injection and some increase in joint pain and headaches which should be accounted for during trial. There are no known health risks associated with IGF1-LR3 injections, especially when compared to traditional hormone-based metabolic, strengthening and growth treatments when compared side by side in animal studies.

IGF1-LR3 dosage

The recommended dosage for IGF-1 LR3 is 40–50 mcg daily, intramuscularly per injection

Aditpotide, also known as FTPP, is an experimental weight loss peptidomimetic with the amino acid sequence CKGGRAKDC-GG-D(KLAKLAK)2, which has been developed by researchers in the United States in an effort to fight obesity. Peptidomimetics are small protein-like chains designed to mimic a peptide. The peptide called Adipotide has been developed by U.S. researchers in the fight against obesity. This experimental treatment has reduced by 11% the weight of the treated monkeys by reducing fatty tissue, the BMI, and waist circumference.

Aditpotide side effects

Aditopotide has the ability to diminish blood vessels in soft tissue that feed fat cells under laboratory conditions with few if any side effects such as redness or itching at site of injection and some minor dehydration which should be accounted for during trial. There are no known health risks associated with DSIP injections, especially when compared to traditional hormone-based

Follistatin also known as activin-binding protein is a protein that in humans is encoded by the FST gene. Follistatin is an autocrine glycoprotein that is expressed in nearly all tissues of higher animals. Its primary function is the binding and bio neutralization of members of the TGF-β superfamily, with a particular focus on activin, a paracrine hormone.

In short, follistatin has been reported to boost metabolism, grow muscle, and increase fertility in laboratory animal trials.

Follistatin side effects

Follistatin has the ability to promote muscle growth and strength under laboratory conditions with few if any side effects such as redness or itching at site of injection and some minor muscle swelling and soreness. There are no known health risks associated with DSIP injections, especially when compared to traditional hormone-based metabolic, strengthening and fertility treatments when compared side by side in animal studies.